Kura Oncology, Inc. (KURA)
USD 9.12
(-6.37%)
USD 9.12
(-6.37%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -124.82 Million | -110.06 Million | -104.55 Million | -69.83 Million | -54.76 Million | -48.65 Million |
| Net Income | -152.63 Million | -135.84 Million | -130.46 Million | -89.62 Million | -63.14 Million | -60.44 Million |
| Depreciation & Amortization | 849 Thousand | 759 Thousand | 558 Thousand | 194 Thousand | - | 10 Thousand |
| Deferred income taxes | -19.45 Million | - | 4.6 Million | - | - | -1.43 Million |
| Stock-based compensation | 28.08 Million | 26.31 Million | 23.57 Million | 12.8 Million | 9.4 Million | 8.65 Million |
| Change in working capital | 7.81 Million | -2.98 Million | -3.22 Million | 6.38 Million | 74 Thousand | 4.38 Million |
| Other non-cash items | 10.51 Million | 1.68 Million | 399 Thousand | 410 Thousand | -1.1 Million | 184 Thousand |
| Investing Cash Flow | 15.55 Million | 32.62 Million | -126.83 Million | -99.93 Million | -46.32 Million | -79.3 Million |
| Investments in PPE | -168 Thousand | -626 Thousand | -1.14 Million | -2.17 Million | - | - |
| Acquisitions | -15.55 Million | -33.25 Thousand | 125.68 Thousand | 97.76 Thousand | - | - |
| Investment purchases | -409.82 Million | -270.65 Million | -445.65 Million | -320.96 Million | -227.57 Million | -237.44 Million |
| Sales/Maturities of investments | 425.54 Million | 303.9 Million | 319.96 Million | 223.19 Million | 181.24 Million | 158.14 Million |
| Other Investing Activities | 15.55 Million | 33.25 Thousand | -125.68 Thousand | -97.76 Thousand | -46.32 Thousand | -79.3 Thousand |
| Financing Cash Flow | 94.78 Million | 38.56 Million | -3.43 Million | 469.33 Million | 111.1 Million | 132.64 Million |
| Debt repayment | - | -9.42 Million | -7.25 Million | -250 Thousand | - | -1.25 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 94.78 Million | 24.72 Million | 4.42 Million | 459.33 Million | 108.16 Million | 132.17 Million |
| Other Financing Activities | 94.78 Million | 23.26 Million | -611 Thousand | 10.24 Million | 2.93 Million | 1.71 Million |
| Accounts receivables | - | - | - | - | 210 Thousand | -8000.00 |
| Accounts payables | 10.32 Million | -802 Thousand | -2.51 Million | 5.67 Million | 856 Thousand | 5.1 Million |
| Inventory | - | - | - | - | -856 Thousand | -443 Thousand |
| Other working capital | -2.5 Million | -2.18 Million | -706 Thousand | 707 Thousand | -136 Thousand | -270 Thousand |
| Cash at beginning of period | 51.8 Million | 90.88 Million | 325.7 Million | 26.13 Million | 16.11 Million | 11.43 Million |
| Cash at end of period | 37.31 Million | 52.01 Million | 90.88 Million | 325.7 Million | 26.13 Million | 16.11 Million |
| Capital Expenditure | -168 Thousand | -626 Thousand | -1.14 Million | -2.17 Million | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -14.48 Million | -38.87 Million | -234.82 Million | 299.56 Million | 10.01 Million | 4.68 Million |
| Free Cash Flow | -124.99 Million | -110.68 Million | -105.69 Million | -72 Million | -54.76 Million | -48.65 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -50.83 Million | -49.52 Million | -42.78 Million | -152.63 Million | -38.6 Million | -37.17 Million |
| Depreciation & Amortization | 202 Thousand | 234 Thousand | 214 Thousand | 849 Thousand | 216 Thousand | 213 Thousand |
| Deferred income taxes | - | - | 5 Million | -19.45 Million | -2.89 Million | -2.11 Million |
| Stock-based compensation | 8.43 Million | 8.51 Million | 7.16 Million | 28.08 Million | 7.09 Million | 6.98 Million |
| Change in working capital | 3.09 Million | -4.91 Million | 3.71 Million | 7.81 Million | 5.03 Million | 6.34 Million |
| Other non-cash items | 5.46 Million | 8.96 Million | -7.61 Million | 10.51 Million | 122 Thousand | 121 Thousand |
| Investing Cash Flow | 43.16 Million | -95.33 Million | 42.19 Million | 15.55 Million | 8.55 Million | -46.32 Million |
| Investments in PPE | -16 Thousand | -84 Thousand | -16 Thousand | -168 Thousand | -20 Thousand | -96 Thousand |
| Acquisitions | - | - | -26.48 Thousand | -15.55 Million | -8579.00 | 46.23 Thousand |
| Investment purchases | -161.67 Million | -195.06 Million | -99.68 Million | -409.82 Million | -96.67 Million | -139.62 Million |
| Sales/Maturities of investments | 204.85 Million | 99.81 Million | 141.9 Million | 425.54 Million | 105.25 Million | 93.39 Million |
| Other Investing Activities | 43.18 Million | -95.25 Million | 26.48 Thousand | 15.55 Million | 8579.00 | -46.23 Thousand |
| Financing Cash Flow | 3.04 Million | 148.36 Million | 691 Thousand | 94.78 Million | 84 Thousand | 94 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 3.04 Million | 148.36 Million | 691 Thousand | 94.78 Million | 84 Thousand | 94 Million |
| Other Financing Activities | 3.04 Million | 2.55 Million | 94.78 Million | 94.78 Million | 84.00 | 94 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -50 Thousand | -3.12 Million | 7.64 Million | 10.32 Million | 3.93 Million | 4.11 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 3.14 Million | -1.78 Million | -3.93 Million | -2.5 Million | 1.1 Million | 2.23 Million |
| Cash at beginning of period | 41.5 Million | 37.31 Million | 28.74 Million | 51.8 Million | 49.33 Million | 27.26 Million |
| Cash at end of period | 45.18 Million | 41.5 Million | 37.31 Million | 37.31 Million | 28.74 Million | 49.33 Million |
| Capital Expenditure | -16 Thousand | -84 Thousand | -16 Thousand | -168 Thousand | -20 Thousand | -96 Thousand |
| Effect of forex changes on cash | - | - | -3.94 Million | - | 22.87 Million | -18.93 Million |
| Net cash flow / Change in cash | 3.67 Million | 4.18 Million | 8.57 Million | -14.48 Million | -20.59 Million | 22.06 Million |
| Free Cash Flow | -42.54 Million | -48.92 Million | -34.32 Million | -124.99 Million | -29.04 Million | -25.71 Million |
IDKOF
SIMPLEXINF
BS6
HYMTF
DUK-PA
INTEG-B